Recent surprise decisions have upended plaintiffs’ expectations on the toxic tort front. In Delaware, the top court is ...

The plaintiffs claim that they developed cancer due to the medication Zantac, which is used to relieve ... result of a defective or inadequate drug label,” the court ruled.

It can perform a host of tasks beyond just putting words down, including a very handy function for creating mailing labels. In this guide, we're going to show you how to print labels from Word ...

Amidst this rapidly evolving landscape, white label AI tools have become pivotal for companies seeking to harness the power of AI without the extensive resources typically required for developing such ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused ...

Ten of the plain­tiff-cho­sen ex­perts ex­pect­ed to tes­ti­fy in lit­i­ga­tion over whether the heart­burn drug Zan­tac caused can­cer will be re­viewed by the Delaware Supreme … ...

Pharmaceutical giant GlaxoSmithKline (GSK) and rival drug manufacturers, including Sanofi, Pfizer and Boehringer Ingelheim, have won the right to an appeal hearing by the Delaware Supreme Court ...

New York: Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused ...

Zantac had been pulled off the market after low levels of a "probable carcinogen" were found in samples. The carcinogen, known as NDMA, is not harmful in very small amounts. However, tests showed ...

Twelve days after GSK secured a key win in Florida, with a state court tossing expert testimony on the cancer-causing potential of heartburn drug Zantac (ranitidine), the British company has ...